Cardiovascular risk: what is the role of HDL cholesterol?
Cariou, B.
La Revue du Praticien 66(3): 330-331
2016
ISSN/ISBN: 2101-017X PMID: 30512649 Document Number: 688971
Document emailed within 1 workday
Related Documents
Konstantinov, V.O. 2017: The Role of non-Statin Therapy for Lowering the Concentration of low-Density Lipoprotein Cholesterol and Reducing the Risk of Developing Atherosclerotic Cardiovascular Complications Kardiologiia 57(5): 68-72Saini, H.K.; Arneja, A.S.; Dhalla, N.S. 2004: Role of cholesterol in cardiovascular dysfunction Canadian Journal of Cardiology 20(3): 333-346
Simon, K.; Kowalewski, W.; Dobracki, W. 1987: Evaluation of the indicators of arteriosclerosis risk factors: cholesterol:HDL cholesterol and LDL cholesterol: HDL cholesterol in acute and chronic diseases of the liver Przeglad Lekarski 44(11): 746-750
Berchtold, P.; Berger, M.; Jörgens, V.; Daweke, C.; Chantelau, E.; Gries, F.A.; Zimmermann, H. 1981: Cardiovascular risk factors and HDL-cholesterol levels in obesity International Journal of Obesity 5(1): 1-10
Horibe, H. 1991: Serum cholesterol levels as a risk factor of cardiovascular disease Rinsho Byori. Japanese Journal of Clinical Pathology 39(5): 501-505
Kelly, S.C.; Gonzalo, R.; Petrasko, M. 2014: A focus on cardiovascular risk modification: clinical significance and implementation of the 2013 ACC/AHA cholesterol guidelines South Dakota medicine: the journal of the South Dakota State Medical Association 67(8): 320-323
Hu, D. 2014: Rethinking, comment and query of the 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults Zhonghua xin xue guan bing za zhi 42(1): 3-5
1991: Relation of cholesterol level to cardiovascular mortality among men with and without preexisting cardiovascular disease New England Journal of Medicine 324(1): 60-61
Kałuzny, M.; Bolanowski, M.; Daroszewski, J.; Szuba, A. 2010: The role of fibrinogen and CRP in cardiovascular risk in patients with acromegaly Endokrynologia Polska 61(1): 83-88
Baena Díez, Jé.Miguel.; Del Val García, Jé.Luis.; Alemany Vilches, L.; Martínez Martínez, Jé.Luis.; Tomàs Pelegrina, J.; González Tejón, Ián.; Raidó Quintana, E.María.; Rovira España, Mónica. 2005: Risk of Suffering from Cardiovascular Diseases because of the Clustering of the Modifiable Cardiovascular Risk Factors in the Population Older than 15 years of a Health Care Center in Barcelona Revista espanola de salud publica 79: 365-378
Kleber, M.E.; Winkler, K.; Wolfert, R.L.; Delgado, G. de Moissl; Grammer, T.B.; Dietz, S.; Winkelmann, B.R.; Boehm, B.O.; Winfried März 2011: Lipoprotein Associated Phospholipase A2 Concentration Predicts Total and Cardiovascular Mortality Independently of Established Risk Factors (The Ludwigshafen Risk and Cardiovascular Health Study) Clinical Laboratory 57(9-10): 659-667
Guo, D.; Xu, C. 1997: The role of insulin resistance in the clustering of cardiovascular risk factors Zhonghua Nei Ke Za Zhi 36(4): 250-252
1999: Canadian Cardiovascular Society 1998 Consensus Conference on the Prevention of Cardiovascular Diseases: The Role of the Cardiovascular Specialist Canadian Journal of Cardiology 15 Suppl G: 1g
Osler, M.; Jespersen, N.B.; Lous, J.; Rasmussen, N.K. 1992: Cardiovascular risk factors--extent and self-assessed risk in relation to prevention of cardiovascular diseases. A questionnaire among 3,956 men and women aged 24-65 years in Vejle County, Slangerup and Helsinge municipalities Ugeskrift for Laeger 154(9): 538-543
Tinti, F.; Mitterhofer, A.P.; Muiesan, P. 2012: Liver transplantation: role of immunosuppression, renal dysfunction and cardiovascular risk factors Minerva Chirurgica 67(1): 1-13
Kalinina, A.M.; Chazova, L.V.; Perova, N.V.; Pavlova, L.I.; Shchepkin, V.V. 1993: An increased risk of death from ischemic heart disease in men with low blood concentrations of total cholesterol and low-density lipoprotein cholesterol Terapevticheskii Arkhiv 65(4): 27-32
Titov, V.N. 2000: The functional role of cholesterol: the difference in the pools of cholesterol in the cell and in individual classes of blood lipoproteins (a review of the literature) Klinicheskaia Laboratornaia Diagnostika 2000(3): 3-10
Danchin, N.; Amelineau, E.; Quentzel, S.; Cambou, J.P. 2006: Role of cardiologists in control of risk factors and prescription of secondary-preventive drugs in elderly patients with atherosclerotic cardiovascular disease. The French ELIAGE-MG survey Annales de Cardiologie et d'Angeiologie 55(1): 17-21
Palmieri, L.; Trojani, M.; Vanuzzo, D.; Panico, S.; Pilotto, L.; Dima, F.; Noce, C.L.; Uguccioni, M.; Pede, S.; Giampaoli, S. 2005: Distribution of the global cardiovascular risk in the Italian population: results from the cardiovascular epidemiologic observatory Italian Heart Journal. Suppl: Official Journal of the Italian Federation of Cardiology 6(5): 279-284
Chopeĭ, I.V.; Rosul, M.M.; Hechko, M.M.; Chubirko, K.I.; Korabel'shchykova, M.O.; Ivan'o, N.V. 2014: Cardiovascular continuum: the role of the family doctor in prevention of cardiovascular diseases Wiadomosci Lekarskie 67(2 Pt 2): 243-247